BRENDA HAJJ: Open Payments
NPI 1225041148 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 20 payments from 8 companies in 2025. Trend: 2023 $612 · 2024 $866 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $195 |
| Madrigal Pharmaceuticals | 1 | $119 |
| Novo Nordisk Inc | 1 | $83 |
| Abbott Laboratories | 3 | $70 |
| Amgen Inc. | 3 | $63 |
| Dexcom, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: AIRSUPRA, REZDIFFRA, Wegovy, FREESTYLE LIBRE 3, FARXIGA, REPATHA, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across TX — which companies pay providers there.
